Cystatin-A Degradome Foundation Atlas

Each fragment is characterized using physicochemical features relevant to mass spectrometry, proteomics, and computational peptide analysis.</p><p dir="ltr"><br>Mass Spectrometry and Peptide Metrics:Molecular weightMass-to-charge ratio (m/z)Net chargeIsoelectric point (pI)<br>Biochemical and Biophysical Features:HydrophobicityBoman indexInstability indexAliphatic index<br>Together, these annotations provide a feature-rich computational reference for exploring the detectability, physicochemical behaviour, and potential analytical relevance of cystatin A-derived peptides.</p><p dir="ltr"><br></p><p dir="ltr"><br>Applications in Biomarker Discovery and Biomedical Research</p><p dir="ltr"><br>The Cystatin A Degradome Foundation Atlas can support a broad range of experimental and computational applications, including:<br>Targeted Proteomics: Identification and prioritization of candidate peptides for mass-spectrometry assays.<br>Biomarker Discovery: Exploration of cystatin A-derived peptide candidates associated with epidermal barrier disorders, exfoliative skin conditions, squamous cell carcinoma, mucosal inflammation, and altered proteostasis.<br>Discovery Proteomics: Interpretation and annotation of cystatin A-derived signals detected in mass-spectrometry datasets.<br>Degradomics: Investigation of potential proteolytic processing patterns and fragment populations.<br>Clinical Proteomics: Computational exploration of cystatin A processing in biological fluids, skin barrier interfaces, and disease-associated conditions.<br>Computational Biology: Generation of reference features for peptide-level modelling, degradome analysis, and machine-learning applications.<br>Assay Development: Prioritization of candidate cystatin A peptides for future experimental validation.</p><p dir="ltr"><br></p><p dir="ltr"><br>Data Inclusion and Reproducibility</p><p dir="ltr"><br>The atlas provides a systematic computational representation of the wild-type cystatin A degradome, including the complete set of theoretically generated contiguous peptide fragments and their calculated physicochemical properties.<br>Importantly, this Foundation Atlas represents a theoretical fragment space rather than a catalogue of experimentally confirmed cystatin A peptides.

Experimental proteomic and mass-spectrometry studies will be required to establish which predicted fragments are generated and detectable under physiological or disease-associated conditions.</p><p dir="ltr"><br>Future releases will expand the resource through the incorporation of additional cystatin A variants, experimentally validated cleavage products, and complementary experimental proteomics data.</p>